Insider Transactions in Q1 2022 at Alignment Healthcare, Inc. (ALHC)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Richard A. Cross SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
1,592
-0.53%
|
$17,512
$11.18 P/Share
|
|
Mar 31
2022
|
Donald Steven Furman Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
3,006
-0.16%
|
$33,066
$11.18 P/Share
|
|
Mar 31
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
26,366
-3.26%
|
$290,026
$11.18 P/Share
|
|
Mar 31
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
3,058
-0.26%
|
$33,638
$11.18 P/Share
|
|
Mar 31
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,944
-1.18%
|
$54,384
$11.18 P/Share
|
|
Mar 31
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
6,681
-0.39%
|
$73,491
$11.18 P/Share
|
|
Mar 31
2022
|
Rajesh Shrestha Pres., New Markets & CBO |
SELL
Open market or private sale
|
Direct |
14,224
-7.71%
|
$156,464
$11.18 P/Share
|
|
Mar 08
2022
|
Jody L Bilney Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,556
+26.8%
|
-
|
|
Mar 08
2022
|
Thomas J. Carella Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,075
+28.49%
|
-
|
|
Mar 08
2022
|
David C Hodgson Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,556
+25.11%
|
-
|
|
Mar 08
2022
|
Yon Jorden Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,075
+30.31%
|
-
|
|
Mar 08
2022
|
Joseph S Konowiecki Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,113
+3.69%
|
-
|
|
Mar 08
2022
|
Jeffrey H Margolis Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,316
+26.84%
|
-
|
|
Mar 08
2022
|
Margaret M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,556
+21.66%
|
-
|
|
Mar 08
2022
|
Mark B. Mc Clellan Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,556
+5.34%
|
-
|
|
Mar 08
2022
|
Nicholas Robbert Vorhoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,556
+25.11%
|
-
|
|
Mar 08
2022
|
John E Kao Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
496,689
+38.08%
|
-
|
|
Mar 08
2022
|
Dawn Christine Maroney President, Markets |
BUY
Grant, award, or other acquisition
|
Direct |
206,954
+10.74%
|
-
|
|
Mar 08
2022
|
Robert Thomas Freeman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
136,589
+24.52%
|
-
|
|
Mar 08
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
206,954
+14.77%
|
-
|
|
Mar 08
2022
|
Richard A. Cross SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
49,669
+14.22%
|
-
|
|
Mar 08
2022
|
Jacqueline B Kosecoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,556
+7.32%
|
-
|
|
Jan 03
2022
|
Jody L Bilney Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,674
+50.0%
|
-
|
|
Jan 03
2022
|
Yon Jorden Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,674
+50.0%
|
-
|